PAH
Clinical trials for PAH explained in plain language.
Never miss a new study
Get alerted when new PAH trials appear
Sign up with your email to follow new studies for PAH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fish oil formula could tame inflammation in rare lung disease
Disease control Not yet recruitingThis study tests whether a specially formulated omega-3 supplement, with a high ratio of EPA to DHA, can reduce inflammation and improve blood vessel function in people with pulmonary arterial hypertension (PAH). Participants take four capsules daily for 12 weeks alongside their …
Matched conditions: PAH
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug hopes to ease rare Heart-Lung condition
Disease control Not yet recruitingThis study tests a drug called sotatercept in 40 adults with congenital heart disease and Eisenmenger syndrome, a serious condition where blood flow in the lungs is blocked. The drug is given as a shot every three weeks for 24 weeks. The goal is to see if it safely lowers pressur…
Matched conditions: PAH
Phase: PHASE2 • Sponsor: Philipps University Marburg • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC